In Philly, We Believe Harm Reduction Saves Lives
Substance Use Prevention and Harm Reduction (SUPHR) is a division of the Philadelphia Department of Public Health.
By promoting the dignity, autonomy, and health of people who use drugs, we work to prevent drug-related deaths and the potential harms associated with drug use.
Learn more about SUPHR ⟶
Upcoming Events
“In Philadelphia we see around 4 overdoses a day. We all know someone. Having these resources is critical to keeping each other safe.”
— Joe, age 34
-
![]()
A new hazardous industrial chemical, BTMPS, has been detected in the drug supply.
-
![]()
A new non-opioid veterinary sedative, medetomidine, entered the drug supply.
-
![]()
In 2022, there were 1413 unintentional drug overdose deaths in Philadelphia.
-
![]()
PDPH alert provides guidance on how to treat xylazine withdrawal and wounds.
-
![]()
The X-Waiver is no longer required for DEA registered providers to prescribe buprenorphine.
-
![]()
Fatal overdoses are spiking in North Philly. Here is how SUPHR is responding.
-
![]()
Xylazine (tranq) is the most common adulterant in the Philadelphia drug supply.
-
![]()
Naloxone, the opioid overdose reversal drug, is now available over the counter.
